Status:
COMPLETED
Study in Healthy Male Subjects to Investigate Whether Ketoconazole Affects Plasma Exposure of BI 113823
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Healthy
Eligibility:
MALE
18-50 years
Phase:
PHASE1
Brief Summary
The objective of the study is to investigate whether ketoconazole affects plasma exposure of BI 113823
Eligibility Criteria
Inclusion
- Inclusion criteria:
- healthy male subjects
Exclusion
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT01189175
Start Date
August 1 2010
Last Update
November 1 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
1272.5.1 Boehringer Ingelheim Investigational Site
Biberach, Germany